Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Attention Disorders|November 21, 2007
The reliability and validity of self- and investigator ratings of ADHD in adultsLenard A Adler, Stephen V Faraone, Thomas J Spencer, et al.
Neuropsychobiology|July 3, 2009
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorderJay D Amsterdam, David Williams, David Michelson, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 7, 2010
Personality disorder in ADHD Part 1: Assessment of personality disorder in adult ADHD using data from a clinical trial of OROS methylphenidateErika D Williams, Frederick W Reimherr, Barrie K Marchant, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|May 7, 2010
Personality disorders in ADHD Part 2: The effect of symptoms of personality disorder on response to treatment with OROS methylphenidate in adults with ADHDReid J Robison, Frederick W Reimherr, Phillip D Gale, et al.
The Journal of Clinical Psychiatry|February 8, 2007
Early symptomatic worsening during treatment with fluoxetine in major depressive disorder: prevalence and implicationsCristina Cusin, Maurizio Fava, Jay D Amsterdam, et al.
Biological Psychiatry|July 26, 2005
Emotional dysregulation in adult ADHD and response to atomoxetineFrederick W Reimherr, Barrie K Marchant, Robert E Strong, et al.
Biological Psychiatry|January 28, 2003
Atomoxetine in adults with ADHD: two randomized, placebo-controlled studiesDavid Michelson, Lenard Adler, Thomas Spencer, et al.
The American Journal of Psychiatry|April 1, 2017
A 5-Year Observational Study of Patients With Treatment-Resistant Depression Treated With Vagus Nerve Stimulation or Treatment as Usual: Comparison of Response, Remission, and SuicidalityScott T Aaronson, Peter Sears, Francis Ruvuna, et al.
The Journal of Clinical Psychiatry|March 4, 2011
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depressionJames G Barbee, Thomas R Thompson, Nowal J Jamhour, et al.
Journal of Clinical Psychopharmacology|May 18, 2010
A pooled MADRS/IDS cross-correlation analysis: clinician and patient self-report assessment of improvement in core depressive symptoms with adjunctive aripiprazoleFrederick W Reimherr, Michael L Martin, James M Eudicone, et al.
Pageof 4